A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
To explore the role of peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated derangements in myocardial metabolism in the pathogenesis of diabetic cardiomyopathy, insulinopenic mice with PPARalpha deficiency (PPARalpha(-/-)) or cardiac-restricted overexpression [myosin heavy chain (MHC)-PPAR] were characterized. Whereas PPARalpha(-/-) mice were protected from the development of diabetes-induced cardiac hypertrophy, the combination of diabetes and the MHC-PPAR genotype resulted in a more severe cardiomyopathic phenotype than either did alone. Cardiomyopathy in diabetic MHC-PPAR mice was accompanied by myocardial long-chain triglyceride accumulation. The cardiomyopathic phenotype was exacerbated in MHC-PPAR mice fed a diet enriched in triglyceride containing long-chain fatty acid, an effect that was reversed by discontinuing the high-fat diet and absent in mice given a medium-chain triglyceride-enriched diet. Reactive oxygen intermediates were identified as candidate mediators of cardiomyopathic effects in MHC-PPAR mice. These results link dysregulation of the PPARalpha gene regulatory pathway to cardiac dysfunction in the diabetic and provide a rationale for serum lipid-lowering strategies in the treatment of diabetic cardiomyopathy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metabolic derangements in the diabetic heart are consistent with chronic activation of PPARα/PGC-1α [89, 90]”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [89]
Citations
Cites
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,837
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Lipotoxic heart disease in obese rats: Implications for human obesity
Zhou, Y.-T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1784 · Cited by 1,265
A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture
Pick, E., & Keisari, Y. (1980) · Journal of Immunological Methods · doi:10.1016/0022-1759(80)90340-3 · Cited by 1,217
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14080 · Cited by 879
Self-citationThe cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovacs, A., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214080 · Cited by 763
Self-citationA novel mouse model of lipotoxic cardiomyopathy
Chiu, H.-C., Kovacs, A., Ford, D. A., Hsu, F.-F., Garcia, R., Herrero, P., Saffitz, J. E., & Schaffer, J. E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10947 · Cited by 760
Stone, P. H., Muller, J. E., Hartwell, T., York, B. J., Rutherford, J. D., Parker, C. B., Turi, Z. G., Strauss, H. W., Willerson, J. T., Robertson, T., et al. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90053-3 · Cited by 516
Myocardial utilization of carbohydrate and lipids
Neely, J. R., Rovetto, M. J., & Oram, J. F. (1972) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(72)90029-1 · Cited by 511
Research works printed but not linked: 3
- D D Belke, T S Larsen, E M Gibbs, D L Severson Am J Physiol 279, E1104–E1113 (2000).
- D J Paulson, M F Crass Am J Physiol 242, 1084–1094 (1982).
- T A Nicholl, G D Lopaschuk, J H McNeill Am J Physiol 261, H1053–H1059 (1991).
Cited by
Items 301–400 of 549
Kalinowska, A., Górski, J., Harasim‐Symbor, E., Harasiuk, D., Bonen, A., & Chabowski, A. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.07.008 · Cited by 26
Herrero, P., McGill, J. B., Lesniak, D., Dence, C. S., Scott, S. W., Kisrieva-Ware, Z., & Gropler, R. J. (2008) · Journal of Nuclear Cardiology · doi:10.1007/bf03007360 · Cited by 26
Li, B., Zhao, X., Ding, Y., & Zhang, Y. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118301 · Cited by 25
Proinflammatory cytokine and ligands modulate cardiac peroxisome proliferator‐activated receptors
Lee, T.-I., Kao, Y.-H., Chen, Y., & Chen, Y. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02062.x · Cited by 25
Broussard, J. L., Nelson, M. D., Kolka, C. M., Bediako, I. A., Paszkiewicz, R. L., Smith, L., Szczepaniak, E. W., Stefanovski, D., Szczepaniak, L. S., & Bergman, R. N. (2015) · Diabetologia · doi:10.1007/s00125-015-3767-5 · Cited by 25
Activity of the β-myosin heavy chain antisense promoter responds to diabetes and hypothyroidism
Giger, J. M., Qin, A. X., Bodell, P. W., Baldwin, K. M., & Haddad, F. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01224.2006 · Cited by 25
Role of Peroxisome Proliferator-Activated Receptor α in Diabetic Nephropathy
Chung, S., & Park, C. W. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.4.327 · Cited by 25
Dobrzyń, P., Pyrkowska, A., Jazurek, M., & Dobrzyń, A. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.05.007 · Cited by 24
Pal, P. B., Pal, S., Manna, P., & Sil, P. C. (2012) · Pathophysiology · doi:10.1016/j.pathophys.2012.02.001 · Cited by 24
Antarctic seals: Molecular biomarkers as indicators for pollutant exposure, health effects and diet
Lehnert, K., Weirup, L., Hårding, K. C., Härkönen, T. J., Karlsson, O., & Teilmann, J. (2017) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2017.04.224 · Cited by 24
CCN5 knockout mice exhibit lipotoxic cardiomyopathy with mild obesity and diabetes
Kim, J., Joo, S., Eom, G. H., Lee, S. H., Lee, M.-A., Lee, M., Kim, K. W., Kim, D. H., Kook, H. Y., Kwak, T. H., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207228 · Cited by 24
Bednarski, T. K., Duda, M. K., & Dobrzyń, P. (2022) · Cells · doi:10.3390/cells11193032 · Cited by 23
Xu, Y., Lu, L., Greyson, C. R., Rizeq, M. N., Nunley, K. R., Wyatt, B., Bristow, M. R., Long, C. S., & Schwartz, G. G. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00631.2005 · Cited by 24
Myocardial Ischemic‐reperfusion Injury in a Rat Model of Metabolic Syndrome
Mozaffari, M. S., & Schaffer, S. W. (2008) · Obesity · doi:10.1038/oby.2008.356 · Cited by 23
The paradox of obesity cardiomyopathy and the potential for weight loss as a therapy
Rayner, J. J., Neubauer, S., & Rider, O. J. (2015) · Obesity Reviews · doi:10.1111/obr.12292 · Cited by 23
PPARα Is Necessary for Radiation-Induced Activation of Noncanonical TGFβ Signaling in the Heart
Subramanian, V., Borchard, S., Azimzadeh, O., Sievert, W., Merl‐Pham, J., Mancuso, M., Pasquali, E., Multhoff, G., Popper, B., Zischka, H., et al. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00001 · Cited by 23
Enhancing fatty acid oxidation negatively regulates PPARs signaling in the heart
Liu, Z., Ding, J., McMillen, T. S., Villet, O. M., Tian, R., & Shao, D. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.06.008 · Cited by 22
Chen, W., Lai, Y., Wang, L., Xia, Y., Chen, W., Zhao, X., Mao-hua, Y., Li, Y., Zhang, Y., & Ye, H. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.11.007 · Cited by 22
Jing, L., Li, W., Zhou, L., Li, S., Kou, J., & Song, J. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00781.x · Cited by 22
Zhao, Q. C., Cui, Z., Zheng, Y., Li, Q., Xu, C., Sheng, X., Tao, M., & Xu, H. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170572 · Cited by 22
Suzuki, J., Ueno, M., Uno, M., Hirose, Y., Zenimaru, Y., Takahashi, S., Osuga, J.-I., Ishibashi, S., Takahashi, M., Hirose, M., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.91031.2008 · Cited by 22
The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure
Riggs, K. A., Ali, H., Taegtmeyer, H., & Gutierrez, A. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0038 · Cited by 22
Yang, R., Pang, J., Zhong, X. Y., Pang, S., Hu, X., Wei, C., Yan, W., Chen, X., Zhao, R., Xu, B., et al. (2025) · Food & Function · doi:10.1039/d5fo01237f · Cited by 21
Issa, J., Lodewyckx, P., Blasco, H., Bretagne, I. B., Labarthe, F., & Lefort, B. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14449 · Cited by 21
Miklánková, D., Marková, I., Hüttl, M., & Malínská, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1393946 · Cited by 21
Zhong, L., Hou, X., Tian, Y., & Fu, X. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02702-y · Cited by 22
Jing, L., Zhou, L., Li, W., Zhang, F., Yuan, L., Li, S., Song, J., & Sang, Y. (2011) · Medical Science Monitor · doi:10.12659/msm.881311 · Cited by 21
Wheelock, C. E., Goto, S., Hammock, B. D., & Newman, J. W. I. (2007) · Metabolomics · doi:10.1007/s11306-007-0052-8 · Cited by 21
Cresci, S., Huss, J. M., Beitelshees, A. L., Jones, P. G., Minton, M. R., Dorn, G. W., Kelly, D. P., Spertus, J. A., & McLeod, H. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012584 · Cited by 20
Self-citationThe antithetic role of ceramide and sphingosine‐1‐phosphate in cardiac dysfunction
Cirillo, F., Piccoli, M., Ghiroldi, A., Monasky, M. M., Rota, P., Rocca, P. L., Tarantino, A., D’Imperio, S., Signorelli, P., Pappone, C., et al. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30235 · Cited by 20
Song, J. W., Kim, H. J., Lee, H., Kim, J. W., & Kwak, Y. L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3539649 · Cited by 20
Role of 14-3-3 protein and oxidative stress in diabetic cardiomyopathy
Watanabe, K., Thandavarayan, R. A., Gurusamy, N., Zhang, S., Muslin, A. J., Suzuki, K., Tachikawa, H., Kodama, M., & Aizawa, Y. (2009) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.96.2009.3.3 · Cited by 20
Heart lipid accumulation in obese non-diabetic rats: Effect of weight loss
Pagano, C., Calcagno, A., Granzotto, M., Calabrese, F., Thiene, G., Federspil, G., & Vettor, R. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.05.009 · Cited by 20
Lipoprotein lipase-derived fatty acids: Physiology and dysfunction
Lee, J., & Goldberg, I. J. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0085-4 · Cited by 20
Pellieux, C., Montessuit, C., Papageorgiou, I., Pedrazzini, T., & Lerch, R. A. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01023.2011 · Cited by 20
Wang, L., Bi, X., & Han, J. (2020) · IUBMB Life · doi:10.1002/iub.2337 · Cited by 19
Cardiac-Specific Overexpression of ERRγ in Mice Induces Severe Heart Dysfunction and Early Lethality
Lasheras, J., Pardo, R., Velilla, M., Poncelas, M., Salvatella, N., Simó, R., Ruiz‐Meana, M., Zamora, M., & Villena, J. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158047 · Cited by 19
Changes in Cardiac Metabolism in Prediabetes
de Wit‐Verheggen, V. H. W., & van de Weijer, T. (2021) · Biomolecules · doi:10.3390/biom11111680 · Cited by 19
Gene–Diet Interactions in Cardiovascular Disease
Dimitriou, M., & Dedoussis, G. V. (2012) · Current Nutrition Reports · doi:10.1007/s13668-012-0020-4 · Cited by 19
Cresci, S., Jones, P. G., Sucharov, C. C., Marsh, S., Lanfear, D. E., Garsa, A., COURTOIS, M. R., Weinheimer, C. J., Wu, J., Province, M. A., et al. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.10.1403 · Cited by 19
Self-citationFillmore, N., Hou, V., Sun, J., Springer, D., & Murphy, E. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265007 · Cited by 18
Ledee, D. R., Portman, M. A., Kajimoto, M., Isern, N., & Olson, A. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065532 · Cited by 18
Fantinelli, J. C., Arbeláez, L. F. G., Núñez, I. A. P., & Mosca, S. M. (2012) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2012.07.004 · Cited by 18
Hamilton, A., Ly, J. D., Robinson, J. R., Corder, K. R., DeMoranville, K. J., Schaeffer, P. J., & Huss, J. M. (2018) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2018.08.009 · Cited by 18
What We Know and Do Not Know about Sex and Cardiac Disease
Konhilas, J. P. (2010) · BioMed Research International · doi:10.1155/2010/562051 · Cited by 18
Haffar, T., Akoumi, A., & Bousette, N. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000453154 · Cited by 18
Intrinsic and extrinsic regulation of cardiac lipoprotein lipase following diabetes
Wang, Y., & Rodrigues, B. B. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.11.007 · Cited by 17
Bhatti, S. N., & Li, J. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.05.162 · Cited by 17
The Effects of a PPARα Agonist on Myocardial Damage in Obese Diabetic Mice With Heart Failure
Chen, R., Liang, F.-X., Morimoto, S., Li, Q., Moriya, J., Yamakawa, J.-I., Takahashi, T., Iwai, K., & Kanda, T. (2010) · International Heart Journal · doi:10.1536/ihj.51.199 · Cited by 17
Krishnamurthy, K., Glaser, S. S., Alpini, G. D., Cardounel, A. J., Liu, Z., & Ilangovan, G. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw094 · Cited by 17
RetractedDiabetic Cardiomyopathy – to Take a Long Story Serious
Stratmann, B., Gawlowski, T., & Tschoepe, D. (2010) · Herz · doi:10.1007/s00059-010-3336-0 · Cited by 17
Ovarian estradiol production and lipid metabolism in postmenopausal women
Maruoka, R., Tanabe, A., Watanabe, A., Nakamura, K., Ashihara, K., Tanaka, T., Terai, Y., & Ohmichi, M. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000221 · Cited by 17
Ham, J., Hwang, H., Kim, E., Kim, J.-A., Cho, S. J., Ko, J., Lee, W., Lee, J., Holla, H., Banerjee, J., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.03.055 · Cited by 17
Lasheras, J., Vilà, M., Zamora, M., Riu, E., Pardo, R., Poncelas, M., Cases, I., Ruiz‐Meana, M., Hernández, C., Felíu, J. E., et al. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.04.004 · Cited by 16
High fat diet altered cardiac metabolic gene profile in Psammomys obesus gerbils
Sahraoui, A., Dewachter, C., Vegh, G., Entee, K. M., Naeije, R., Bouguerra, S. A., & Dewachter, L. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01301-y · Cited by 16
Finck, B. N. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.2.161 · Cited by 17
Self-citationExerkines: Potential regulators of diabetic cardiomyopathy
Yu, F., Zong, B., Tian, Z., Jia, D., & Wang, R. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102816 · Cited by 15
Cao, S., Liu, Y., Sun, W., Zhao, L., Zhang, L., Liu, X., & Yu, T. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/756576 · Cited by 15
From Beats to Metabolism: the Heart at the Core of Interorgan Metabolic Cross Talk
Romero-Becerra, R., Santamans, A. M., Arcones, A. C., & Sabio, G. (2023) · Physiology · doi:10.1152/physiol.00018.2023 · Cited by 15
Metabolic stress in the myocardium: Adaptations of gene expression
Crawford, P. A., & Schaffer, J. E. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.06.008 · Cited by 16
Ojha, S. K., Kurdi, A., Sadek, B. S., Kaleem, M., Cai, L., Kamal, M. A., & Rajesh, M. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160322145255 · Cited by 15
Salacia – The new multi-targeted approach in diabetics
Vyas, N., Mehra, R., & Makhija, R. (2016) · AYU (An International Quarterly Journal of Research in Ayurveda) · doi:10.4103/ayu.ayu_134_13 · Cited by 15
Kruppel-like factor 15 is required for the cardiac adaptive response to fasting
Sugi, K., Hsieh, P. N., Ilkayeva, O., Shelkay, S., Moroney, B., Baadh, P., Haynes, B., Pophal, M., Fan, L., Newgard, C. B., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192376 · Cited by 15
Peroxisome proliferator-activated receptor gamma agonist action of 3-methyl-1,2-cyclopentanedione
Choi, S. Y., Chung, J. H., Kim, D. H., Chung, S. W., Kim, J., Yu, B. P., & Chung, H. Y. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.08.006 · Cited by 15
MG53 and disordered metabolism in striated muscle
Hu, X., & Xiao, R. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.013 · Cited by 15
PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease
Cresci, S. (2008) · PPAR Research · doi:10.1155/2008/374549 · Cited by 15
Regulation of Plasma Fructose and Mortality in Mice by the Aldose Reductase Inhibitor Lidorestat
Noh, H. L., Hu, Y., Park, T., DiCioccio, T., Nichols, A. J., Okajima, K., Homma, S., & Goldberg, I. J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.136283 · Cited by 16
The Pivotal Role of Mitsugumin 53 in Cardiovascular Diseases
Jiang, W., Liu, M., Gu, C., & Ma, H. (2020) · Cardiovascular Toxicology · doi:10.1007/s12012-020-09609-y · Cited by 14
Protective role of MG53 against ischemia/reperfusion injury on multiple organs: A narrative review
Xu, B., Wang, C., Chen, H., Zhang, L., Gong, L., Zhong, L., & Yang, J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1018971 · Cited by 14
Forte, M., Rodolico, D., Ameri, P., Catalucci, D., Chimenti, C., Crotti, L., Schirone, L., Pingitore, A., Torella, D., Iacovone, G., et al. (2022) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001397 · Cited by 14
PPARα: its role in the human metabolic syndrome
Azhar, S., & Kelley, G. (2007) · Future Lipidology · doi:10.2217/17460875.2.1.31 · Cited by 14
The Role of Environmental Obesogens in the Obesity Epidemic
Janesick, A., & Blumberg, B. (2010) · Endocrine updates · doi:10.1007/978-1-4419-7034-3_19 · Cited by 14
Liu, H. Y., Zheng, G., Zhu, H., & Woldegiorgis, G. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.06.026 · Cited by 14
Shim, J.-U., & Lim, K. (2008) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2008.06.005 · Cited by 14
Sharma, V. S., Dhillon, P., Parsons, H., Allard, M. F., & McNeill, J. H. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.02.016 · Cited by 14
Weeks, K. L., Kiriazis, H., Wadley, G. D., Masterman, E. I., Sergienko, N. M., Raaijmakers, A. J. A., Trewin, A. J., Harmawan, C. A., Yildiz, G. S., Liu, Y., et al. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02397-2 · Cited by 13
Yan, J. X., Song, K., Bai, Z., & Ge, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118888 · Cited by 13
Fish Oil Selectively Improves Heart Function in a Mouse Model of Lipid-induced Cardiomyopathy
Khan, R. S., Chokshi, A. D., Drosatos, K., Jiang, H., Yu, S., Harris, C. R., Schulze, P. C., Homma, S., Blaner, W. S., Shulman, G. I., et al. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318283d845 · Cited by 13
Therapy with Astragalus polysaccharides rescues lipotoxic cardiomyopathy in MHC-PPARα mice
Chen, W., Chen, W., Xia, Y., Zhao, X., Wang, H., Mao-hua, Y., Li, Y., Ye, H., & Zhang, Y. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2325-1 · Cited by 13
Untangling the Cooperative Role of Nuclear Receptors in Cardiovascular Physiology and Disease
Paredes, A. L., Santos-Clemente, R., & Ricote, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157775 · Cited by 13
The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics
Cresci, S. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.15.2577 · Cited by 13
Li, Y., Gu, Y., Song, Y., Zhang, L., Kang, Y. J., Prabhu, S. D., & Cai, L. (2004) · Eisei kagaku · doi:10.1248/jhs.50.356 · Cited by 13
Girona, J., Soler, O., Samino, S., Junza, A., Martínez-Micaelo, N., García‐Altares, M., Ràfols, P., Esteban, Y., Yanes, Ó., Correig, X., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052702 · Cited by 12
Lipotoxicity as a therapeutic target in the type 2 diabetic heart
Luong, T. V. T., Yang, S., & Kim, J. (2025) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2025.02.010 · Cited by 12
Myocardial steatosis impairs left ventricular diastolic–systolic coupling in healthy humans
Oneglia, A. P., Szczepaniak, L. S., JAFFERY, M. F., Cipher, D. J., McDonald, J. G., Haykowsky, M. J., Moreau, K. L., Clegg, D. J., Zaha, V. G., & Nelson, M. D. (2023) · The Journal of Physiology · doi:10.1113/jp284272 · Cited by 12
New insights into the roles of olfactory receptors in cardiovascular disease
Shi, K., Jiao, Y., Yang, L., Yuan, G., & Jia, J. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05024-x · Cited by 12
Synthesis, radiolabeling and initial in vivo evaluation of [11C]KSM-01 for imaging PPAR-α receptors
Sai, K. K. S., Kil, K.-E., Tu, Z., Chu, W., Finck, B. N., Rothfuss, J. M., Shoghi, K. I., Welch, M. J., Gropler, R. J., & Mach, R. H. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.08.010 · Cited by 12
Self-citationPerreault, M., Will, S., Panza, D., Gareski, T., Harding, K., Kubasiak, D., Jalenak, M., Gartrell, K., Wang, S., Bollag, G. E., et al. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01157.x · Cited by 12
Makaula, S., Adam, T., & Essop, M. F. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2005.10.025 · Cited by 12
Yan, K., Mei, Z., Zhao, J., Prodhan, M. A. I., Obal, D., Katragadda, K., Doeling, B., Hoetker, D., Posa, D. K., He, L., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023868 · Cited by 11
The role of PPARs in modulating cardiac metabolism in diabetes
Holness, M. J., Samsuddin, S., & Sugden, M. C. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.04.006 · Cited by 11
Heitmeier, M. R., Payne, M., Weinheimer, C. J., Kovács, A. D., Hresko, R. C., Jay, P. Y., & Hruz, P. W. (2018) · Scientific Reports · doi:10.1038/s41598-018-24867-1 · Cited by 11
Positioning Metabolism as a Central Player in the Diabetic Heart
Mereweather, L. J., Aparicio, C. N. M., & Heather, L. C. (2020) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2020.9.1.92 · Cited by 11
Jafarynezhad, F., Shahbazian, M., Farhadi, Z., Yadeghari, M., Rezvani, M. E., Safari, F., & Azizian, H. (2022) · Intern J Endocrinol Metab · doi:10.5812/ijem-123560 · Cited by 11
Diabetic Cardiomyopathy: A New Perspective of Mechanistic Approach
Muralidaran, Y., & Viswanathan, P. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000605 · Cited by 11
AMP-activated protein kinase in the heart: role in cardiac glucose and fatty acid metabolism
Kewalramani, G., & Rodrigues, B. B. (2009) · Clinical Lipidology · doi:10.2217/clp.09.43 · Cited by 10
Vitamin A preserves cardiac energetic gene expression in a murine model of diet-induced obesity
Naasner, L., Froese, N., Hofmann, W. A., Galuppo, P., Werlein, C., Shymotiuk, I., Szaroszyk, M., Erschow, S., Amanakis, G., Bähre, H., et al. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00514.2022 · Cited by 10
Ismael, S., & Nair, R. R. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03925-1 · Cited by 10
Salvi, N., Guellich, A., Michelet, P., Demoule, A., Guen, M. L., Renou, L., Bonne, G., Riou, B., Langeron, O., & Coirault, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011494 · Cited by 10
Metadata
- Authors
- Finck, B. N., Han, X., Courtois, M., Aimond, F., Nerbonne, J. M., Kovacs, A., Gross, R. W., & Kelly, D. P.
- Affiliations
- Washington University in St. Louis (US)
- Departments of Medicine, Molecular Biology and Pharmacology, and Pediatrics, Center for Cardiovascular Research, Washington University School of Medicine, St. Louis, MO 63110
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-01-27
- Volume
- 100
- Issue
- 3
- Pages
- 1226-1231
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC298755
- OpenAlex
- W1968715224
- Cited by
- 501
- References
- 26
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 6 · 2023: 8 · 2022: 11 · 2021: 18 · 2020: 16 · 2019: 12 · 2018: 14 · 2017: 16 · 2016: 19 · 2015: 20 · 2014: 27 · 2013: 27 · 2012: 31
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DK-52574, DK56341, HL57278)
- National Heart, Lung, and Blood Institute (P01HL57278, P01 HL 13851, P01HL057278, P01HL013851, F32HL067575)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK-52574, R01 DK45416, R01DK045416, P30-DK56341, P30DK056341, P30DK052574)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- diabetic cardiomyopathy, PPARα, lipotoxicity, dietary fat, medium-chain triglycerides, cardiac hypertrophy, reactive oxygen species, myocardial metabolism, lipid-lowering therapy
- MeSH terms
- Adenosine Triphosphate, Animals, Ceramides, Diabetes Mellitus, Experimental, Diabetic Angiopathies, Dietary Fats, Echocardiography, Electrophysiology, Glutathione, Hydrogen Peroxide, Cardiomyopathies, Myocardium, Phenotype, Time Factors, Transcription Factors, Triglycerides, Blotting, Northern, Receptors, Cytoplasmic and Nuclear, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.